Bratland E - Search Results

1

Identification and characterization of rare toll-like receptor 3 variants in patients with autoimmune Addison's disease.

Aslaksen S, Wolff AB, Vigeland MD, Breivik L, Sheng Y, Oftedal BE, Artaza H, Skinningsrud B, Undlien DE, Selmer KK, Husebye ES, Bratland E. Aslaksen S, et al. Among authors: bratland e. J Transl Autoimmun. 2019 May 28;1:100005. doi: 10.1016/j.jtauto.2019.100005. eCollection 2019 Apr. J Transl Autoimmun. 2019. PMID: 32743495 Free PMC article.

2

The substrate-binding domain of 21-hydroxylase, the main autoantigen in autoimmune Addison's disease, is an immunodominant T cell epitope.

Husebye ES, Bratland E, Bredholt G, Fridkin M, Dayan M, Mozes E. Husebye ES, et al. Among authors: bratland e. Endocrinology. 2006 May;147(5):2411-6. doi: 10.1210/en.2006-0018. Epub 2006 Feb 23. Endocrinology. 2006. PMID: 16497795

3

Epitope mapping of human aromatic L-amino acid decarboxylase.

Bratland E, Wolff AS, Haavik J, Kämpe O, Sköldberg F, Perheentupa J, Bredholt G, Knappskog PM, Husebye ES. Bratland E, et al. Biochem Biophys Res Commun. 2007 Feb 16;353(3):692-8. doi: 10.1016/j.bbrc.2006.12.080. Epub 2006 Dec 22. Biochem Biophys Res Commun. 2007. PMID: 17194446

4

Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I.

Oftedal BE, Wolff AS, Bratland E, Kämpe O, Perheentupa J, Myhre AG, Meager A, Purushothaman R, Ten S, Husebye ES. Oftedal BE, et al. Among authors: bratland e. Clin Immunol. 2008 Oct;129(1):163-9. doi: 10.1016/j.clim.2008.07.002. Epub 2008 Aug 16. Clin Immunol. 2008. PMID: 18708298

5

The purification and application of biologically active recombinant steroid cytochrome P450 21-hydroxylase: the major autoantigen in autoimmune Addison's disease.

Bratland E, Bredholt G, Mellgren G, Knappskog PM, Mozes E, Husebye ES. Bratland E, et al. J Autoimmun. 2009 Aug;33(1):58-67. doi: 10.1016/j.jaut.2009.02.018. Epub 2009 Mar 28. J Autoimmun. 2009. PMID: 19329278

6

T cell responses to steroid cytochrome P450 21-hydroxylase in patients with autoimmune primary adrenal insufficiency.

Bratland E, Skinningsrud B, Undlien DE, Mozes E, Husebye ES. Bratland E, et al. J Clin Endocrinol Metab. 2009 Dec;94(12):5117-24. doi: 10.1210/jc.2009-1115. Epub 2009 Nov 4. J Clin Endocrinol Metab. 2009. PMID: 19890026

7

Cellular immunity and immunopathology in autoimmune Addison's disease.

Bratland E, Husebye ES. Bratland E, et al. Mol Cell Endocrinol. 2011 Apr 10;336(1-2):180-90. doi: 10.1016/j.mce.2010.12.015. Epub 2010 Dec 15. Mol Cell Endocrinol. 2011. PMID: 21167251 Review.

8

Induction of CXCL10 chemokine in adrenocortical cells by stimulation through toll-like receptor 3.

Bratland E, Hellesen A, Husebye ES. Bratland E, et al. Mol Cell Endocrinol. 2013 Jan 5;365(1):75-83. doi: 10.1016/j.mce.2012.09.004. Epub 2012 Sep 16. Mol Cell Endocrinol. 2013. PMID: 22989785

9

Autoantibodies against aromatic amino acid hydroxylases in patients with autoimmune polyendocrine syndrome type 1 target multiple antigenic determinants and reveal regulatory regions crucial for enzymatic activity.

Bratland E, Magitta NF, Bøe Wolff AS, Ekern T, Knappskog PM, Kämpe O, Haavik J, Husebye ES. Bratland E, et al. Immunobiology. 2013 Jun;218(6):899-909. doi: 10.1016/j.imbio.2012.10.006. Epub 2012 Oct 26. Immunobiology. 2013. PMID: 23182718

10

The effect of types I and III interferons on adrenocortical cells and its possible implications for autoimmune Addison's disease.

Hellesen A, Edvardsen K, Breivik L, Husebye ES, Bratland E. Hellesen A, et al. Among authors: bratland e. Clin Exp Immunol. 2014 Jun;176(3):351-62. doi: 10.1111/cei.12291. Clin Exp Immunol. 2014. PMID: 24666275 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page